| SKU | Size | Availability | Price | Qty |
|---|---|---|---|---|
| P475627-1g | 1g | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $675.90 |
| Specifications & Purity | PEG average Mₙ 5,000, PLGA Mₙ 5,000, lactide:glycolide 50:50 |
|---|---|
| Storage Temp | Store at -20°C |
| Shipped In | Ice chest + Ice pads |
| Product Description | Contains ≤500 ppm impurities by GC, including trace monomer and residual organics.Biocompatible block copolymer that can be used in the formation of nanoparticles for drug delivery. Potenial use in the targeted and/or controlled release of cancer drugs, anti-inflammatory drugs, antibiotics, or anesthetic agents. |
Enter Lot Number to search for COA:
| 1. Yihan Xu, Chang-Soo Kim, David M Saylor, Donghun Koo,. (2016-04-22) Polymer degradation and drug delivery in PLGA-based drug-polymer applications: A review of experiments and theories.. Journal of biomedical materials research. Part B, Applied biomaterials, 105 ((6)): ( 1692-1716 ). [PMID:27098357] |
